Drug intelligence / Profile preview

keishi-ka-shakuyaku-daio-to

Development stage
Unknown
Lead developer
Tsumura
Modality
Small Molecules
Administration
Oral
01

Overview

Keishi-ka-shakuyaku-daio-to (TJ-134) is a traditional Japanese Kampo medicine composed of six crude drug extracts: peony root, cinnamon bark, jujube, glycyrrhiza, rhubarb, and ginger. It is a pharmacological modification of Keishi-ka-shakuyaku-to, specifically augmented with rhubarb (*Rhei Rhizoma*) to address symptoms involving abdominal pain and constipation. The formulation contains various bioactive compounds, including paeoniflorin, glycyrrhizin, and sennosides. It functions as both an antispasmodic and a stimulant laxative. Clinically, it is used for patients exhibiting abdominal pain with tenesmus and constipation, and it is currently being investigated for the treatment of symptomatic Pneumatosis Cystoides Intestinalis (PCI) due to its potential to reduce intraluminal pressure and facilitate gas expulsion.

Brand names
Tsumura Keishikashakuyakudaioto Extract Granules
Other names
keishikashakuyakudaiotogui-zhi-jia-shao-yao-da-huang-tangk-s-d
02

Targets

HTR3A (5-hydroxytryptamine receptor 3A)HSD11B2 (11β-HSD2)TRPA1 (Transient receptor potential cation channel subfamily A member 1)

Beyond the preview

Go deeper on keishi-ka-shakuyaku-daio-to.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on keishi-ka-shakuyaku-daio-to.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call